Gerald S. Falchook
MD, MS
Director, Drug Development Unit
👥Biography 个人简介
Gerald Falchook directs a high volume phase I unit and has been principal investigator on numerous first-in-human oncology studies. He has contributed to the development of BRAF, MEK, and PI3K inhibitors and novel immunotherapies. His work emphasizes pharmacodynamic endpoints and biomarker-driven cohorts.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 Gerald S. Falchook 的研究动态
Follow Gerald S. Falchook's research updates
留下邮箱，当我们发布与 Gerald S. Falchook（Sarah Cannon Research Institute at HealthONE）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment